What is the significance of focal fatty infiltration of the liver, a probable gallbladder polyp, and a possible non‑mobile gallstone on imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Understanding Your Imaging Findings

These imaging findings describe three separate liver and gallbladder conditions that are commonly seen together and generally benign, but the gallbladder polyp requires size-based risk stratification and potential follow-up according to established guidelines.

What Each Finding Means

Focal Fatty Infiltration of the Liver

This refers to localized areas where fat has accumulated in liver tissue, while surrounding liver remains relatively normal. Focal fatty infiltration is a benign finding that does not increase mortality or affect quality of life 1, 2.

  • Common locations: Most frequently occurs around the gallbladder fossa (segments 4 and 5 of the liver) 1
  • Mechanism: Related to aberrant blood flow patterns, particularly from gallbladder vessels that alter local fat distribution 3, 1
  • Clinical significance: This is NOT a tumor or malignancy—it's simply uneven fat distribution in the liver
  • Association: Fatty liver itself is independently associated with gallbladder polyps 4

Key point: When focal fatty sparing (the reverse pattern) appears around the gallbladder, it occurs in 67-78% of patients with fatty liver who have an intact gallbladder, but only 33% after cholecystectomy 1. This confirms the gallbladder's blood supply influences local liver fat patterns.

Probable Gallbladder Polyp

A gallbladder polyp is defined as a solid, non-mobile, non-shadowing protrusion from the gallbladder wall 5.

Management depends entirely on polyp size 5:

If polyp is ≤5 mm:

  • No follow-up required if you have no risk factors 6
  • Zero documented cases of malignancy at this size in multiple large studies 5
  • Up to 83% of apparent 5mm polyps are not found at subsequent surgery (often adherent debris) 5

If polyp is 6-9 mm:

  • Without risk factors: Ultrasound follow-up at 6 months, 1 year, and 2 years 6
  • With risk factors: Consider cholecystectomy 6
  • Risk factors include: age >60 years, primary sclerosing cholangitis, Asian ethnicity, sessile (broad-based) shape, or focal wall thickening >4mm 6

If polyp is 10-14 mm:

  • Surgical consultation recommended based on patient factors or growth 5
  • Malignancy risk increases but remains low (8.7 per 100,000 patients) 5

If polyp is ≥15 mm:

  • Cholecystectomy strongly recommended if surgically fit 5, 6
  • Size ≥15mm is an independent predictor of neoplastic polyps 5

Non-mobile Stone Not Excluded

This phrase indicates the radiologist cannot definitively distinguish between:

  • A true gallbladder polyp (attached to the wall)
  • An adherent gallstone (stuck to the wall but not a true polyp)
  • Tumefactive sludge (coalesced bile that mimics a mass) 5

Next step if unclear 5:

  • Repeat ultrasound in 1-2 months with optimized technique (patient fasting, proper positioning, color Doppler)
  • If still uncertain and lesion is ≥10mm: Consider contrast-enhanced ultrasound (CEUS) or MRI for characterization
  • True polyps show internal vascularity on Doppler; stones and sludge do not 5

Recommended Action Plan

Step 1: Determine the exact size of the "probable polyp" from your imaging report

Step 2: Apply the size-based algorithm above

Step 3: If the report doesn't specify size or characterization is uncertain:

  • Request repeat ultrasound with optimized technique in 1-2 months
  • Ensure you're fasting 6-8 hours before the exam
  • Request color Doppler imaging to assess vascularity

Step 4: Assess your risk factors (age >60, PSC history, Asian ethnicity)

Common Pitfalls to Avoid

  • Don't assume all gallbladder wall lesions are polyps: Many are adherent stones or sludge that resolve on repeat imaging 5
  • Don't over-surveil tiny polyps: Polyps ≤5mm without risk factors need no follow-up 6
  • Don't ignore growth: Any growth of ≥2mm during surveillance warrants reassessment 6
  • Don't confuse focal fatty infiltration with a liver mass: This is a benign metabolic finding, not a tumor 7, 8

Bottom Line

The focal fatty infiltration is benign and requires no specific action. The gallbladder findings require size determination—if the polyp is ≤5mm, no follow-up is needed; if 6-9mm, surveillance ultrasound is appropriate; if ≥10mm, surgical consultation should be considered 5, 6. The uncertainty about whether this is a polyp versus stone necessitates either repeat optimized ultrasound or advanced imaging if the lesion measures ≥10mm 5.

References

Research

Focal sparing of liver parenchyma in steatosis: role of the gallbladder and its vessels.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1995

Research

Analysis of focal spared areas in fatty liver using color Doppler imaging and contrast-enhanced microvessel display sonography.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2008

Research

Fatty liver is an independent risk factor for gallbladder polyps.

World journal of gastroenterology, 2020

Research

[Contrast-enhanced ultrasound of focal fatty sparing].

Deutsche medizinische Wochenschrift (1946), 2011

Research

Value of MR imaging in evaluating focal fatty infiltration of the liver: preliminary study.

Radiographics : a review publication of the Radiological Society of North America, Inc, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.